Skip to main content
Fig. 2 | BMC Complementary Medicine and Therapies

Fig. 2

From: Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway

Fig. 2

Modified PD administration alleviated symptoms of DSS-induced UC

(A) Mice were divided into negative control group, model group (DSS-treated) and three modified PD groups (DSS-treated with modified PD treatment): low dose (3.185 mg/kg), medium dose (6.37 mg/kg) and high dose (12.74 mg/kg). (B) Loss of basal body weight, (C & D) colon length, (E) Pathological score, and (F) HE staining was performed to evaluate the therapeutic effect of modified PD. *: p < 0.05, **: p < 0.01, ***: p < 0.001, Data are expressed as mean ± SEM.

Back to article page